These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22678019)

  • 1. [Therapeutic standards and perspectives for stage IV non-small cell lung cancer].
    Reck M; Rosell R; Tiemann M
    Onkologie; 2012; 35 Suppl 3():10-3. PubMed ID: 22678019
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quality assurance].
    Flentje M; Hoffmann H; Huber RM
    Onkologie; 2012; 35 Suppl 3():14-6. PubMed ID: 22678020
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer.
    Lennes IT; Lynch TJ
    Clin Lung Cancer; 2009 Sep; 10(5):341-6. PubMed ID: 19808192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer.
    Freeman RK; Van Woerkom JM; Vyverberg A; Ascioti AJ
    Eur J Cardiothorac Surg; 2010 Jul; 38(1):1-5. PubMed ID: 20206544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgery and adjuvant therapy in non-small-cell lung carcinoma (NSCLC). (stage I through operable stage IIIA)].
    Eberhardt W; Fietkau R; Griesinger F; Passlick B; Stuschke M
    Onkologie; 2006 Sep; 29 Suppl 2():7-10. PubMed ID: 16974121
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy in non-small-cell lung carcinoma (NSCLC) in local advanced stage (inoperable IIIA/IIIB)].
    Baumann M; Dienemann HC; Fietkau R; Rübe C; Thomas M
    Onkologie; 2006 Sep; 29 Suppl 2():11-4. PubMed ID: 16974122
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in the pattern of care for lung cancer and their correlation with new clinical evidence: experiences in a university-affiliated medical center.
    Chien CR; Lai MS
    Am J Med Qual; 2006; 21(6):408-14. PubMed ID: 17077423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.
    Hermens RP; Ouwens MM; Vonk-Okhuijsen SY; van der Wel Y; Tjan-Heijnen VC; van den Broek LD; Ho VK; Janssen-Heijnen ML; Groen HJ; Grol RP; Wollersheim HC
    Lung Cancer; 2006 Oct; 54(1):117-24. PubMed ID: 16920220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.
    Pfister DG; Johnson DH; Azzoli CG; Sause W; Smith TJ; Baker S; Olak J; Stover D; Strawn JR; Turrisi AT; Somerfield MR;
    J Clin Oncol; 2004 Jan; 22(2):330-53. PubMed ID: 14691125
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing patients with lung cancer. Guidelines must help bring us in line with European standards.
    O'Brien ME; Cullen M
    BMJ; 2000 Jun; 320(7249):1604-5. PubMed ID: 10896440
    [No Abstract]   [Full Text] [Related]  

  • 11. Practice guidelines for non-small cell lung cancer.
    Cameron R; Fringer J; Taylor C; Gilden CR; Figlin RA
    Cancer J Sci Am; 1996; 2(3A Suppl):S61-8. PubMed ID: 9166525
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
    Mornex F
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
    [No Abstract]   [Full Text] [Related]  

  • 13. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
    Wouters MW; Siesling S; Jansen-Landheer ML; Elferink MA; Belderbos J; Coebergh JW; Schramel FM
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Goss G; Paszat L; Newman TE; Evans WK; Browman G
    Cancer Prev Control; 1998 Feb; 2(1):32-9. PubMed ID: 9765764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guideline on 'non-small cell lung carcinoma; staging and treatment'].
    van Meerbeeck JP; Koning CC; Tjan-Heijnen VC; Boekema AG; Kaandorp CJ; Burgers JS
    Ned Tijdschr Geneeskd; 2005 Jan; 149(2):72-7. PubMed ID: 15688837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guide line for the treatment of stage I and stage II non small cell lung cancer].
    Kobayashi K
    Nihon Geka Gakkai Zasshi; 2004 Jul; 105(7):392-403. PubMed ID: 15303438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease.
    Thomas M; Hoffknecht P; Droege C; Baisch A; Reinmuth N; Kreuter M; Lange T; Berdel WE
    Lung Cancer; 2004 Aug; 45 Suppl 2():S99-105. PubMed ID: 15552789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early staging in non-small cell lung cancer].
    Eberhardt W; Griesinger F; Filipits M; Winter H
    Onkologie; 2012; 35 Suppl 3():6-9. PubMed ID: 22678018
    [No Abstract]   [Full Text] [Related]  

  • 19. Lung cancer treatment in New Zealand: physician's attitudes.
    Christmas T; Findlay M
    N Z Med J; 2004 Jun; 117(1196):U931. PubMed ID: 15280935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population variations in the initial treatment of non-small-cell lung cancer.
    Potosky AL; Saxman S; Wallace RB; Lynch CF
    J Clin Oncol; 2004 Aug; 22(16):3261-8. PubMed ID: 15310770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.